Regulatory Knowhow Is One of the Most Important Steps toward Approval.
Keep in Mind that Regulatory Agencies such as the FDA and EMA, for example.
Making a good regulatory plan requires early communication with agencies, setting clear product goals, and developing detailed plans for each drug type. Key steps include identifying the applicable rules, planning lab and human tests, preparing manufacturing documents, and using expedited approval methods. Regularly managing risks and updating the plan are important. Moving from basic research to FDA approval can feel overwhelming at first.
Academics can learn about regulations by joining an incubator or accelerator, or by partnering with someone experienced in turning discoveries into FDA-approved treatments. This helps us use time and resources wisely so patients benefit sooner. It is also important to know who is on the leadership team and to understand each person’s goals and reasons for joining the biotech company.
When to contact the Regulatory Agencies
Because the approval process takes several years to ensure a product’s benefits outweigh its risks, the first step is to contact the appropriate agencies.
Start-ups should reach out to the FDA early, usually as soon as they have a working idea, prototype, or clear plan for use, often through a Pre-Submission (Q-Sub) process. Talking to the FDA a year before submitting an IND (drug) or completing device designs helps identify approval steps, spot potential problems, and plan tests. This saves time and money. Also, having a team member who knows how to get ready for FDA meetings is helpful.
· Building a relationship with regulatory agencies is important because it transforms a potentially confrontational, routine compliance process into a cooperative partnership that reduces development risks, speeds up approval times, and avoids expensive, last-minute project changes. Being proactive builds trust, helping regulators understand your product or business, which can result in clearer advice and a smoother, more predictable review.
1. Start early
Starting early helps sponsors plan in line with regulatory expectations. Being proactive lets teams spot risks and make smarter choices. Preparing in advance builds trust with regulators, which helps secure approval. Focusing on early communication leads to better alignment of development plans, more complete preparation for key steps, and shorter, more predictable timelines.
2. Prepare thoughtfully for each interaction
Early preparation only works if it is careful and thoughtful. Meetings with regulators, whether online or in person, are important chances to align, plan strategies, understand expectations, and reduce risks. Before these meetings, learn about the agency and what information they need. This helps drug developers set clear goals for each meeting and prepare the right materials. Prepare questions based on guidance documents, rules, and past agency decisions to demonstrate your understanding of the process and science. Stay open and respectful during preparations. Regulators want to know about a company’s product, mission, and plans. The more sponsors help them understand, the more trust and credibility they gain.
3. Leverage regulatory programs
A crucial part of understanding the regulatory landscape is awareness of the expedited pathways and enhanced engagement programs that regulatory agencies offer. These programs can drastically expedite timelines and provide further support to teams that qualify. A few examples of these programs include:
Fast Track, Breakthrough Therapy, Accelerated Approval, Priority Review and Orphan Drug Designation in the U.S.
PRIME or Accelerate Assessment in the EU
These programs may also increase the frequency and depth of engagement with regulators. Sponsors’ planning should include research into what programs they may qualify for and what is required to participate.
4. Understand the regulatory perspective
Many successful sponsors achieve their goals by viewing the regulatory process from the regulator’s perspective. Regulatory agencies work based on science and public health needs. Focusing on patients is key to understanding how agencies handle approvals. Regulators may also have particular opinions about certain products or diseases. Teams can learn more by watching public talks or reading articles by reviewers or department leaders.
5.Sponsors should build relationships with regulators that show dedication while adjusting to each agency’s way of working. Balancing formal and cooperative interactions helps create smoother timelines and mutual respect. This means understanding that each agency is different. Some follow strict rules, others are more flexible. Many have limited time and resources, so it’s important to respect these limits.
2026 Regulatory Updates: please keep in mind that the FDA and EMA often make changes it guidelines. It is suggested that you have a team member keep a monitor of Regulatory Agencies bi-weekly. If none of your team members have this experience, then it is wise to collaborate with a company or consultant that has worked with at least the FDA and EMA.